பிராடன் பார்க்கர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிராடன் பார்க்கர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிராடன் பார்க்கர் Today - Breaking & Trending Today

Be The Match BioTherapies and Orchard Therapeutics: Be The Match BioTherapies Announces Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics to Support European Commercial Launch of Libmeldy


(2)
Be The Match BioTherapies will provide streamlined supply chain services in support of Orchard s commercial-stage gene therapy in Europe
Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced an expansion of their multi-year partnership with Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, to include supply chain services in support of the upcoming commercial launch of Libmeldy (autologous CD34+ cells encoding the
ARSA gene), Orchard s gene therapy recently approved in Europe for the treatment of early-onset metachromatic leukodystrophy (MLD).
Through the expanded partnership, Be The Match BioTherapies will provide comprehensive support across the commercial supply chain for Libmeldy, including support of the onboarding and training of apheresis centers, oversight of the autologous cell collection process and delivery of both harvested cells to t ....

United Kingdom , United States , City Of , Gwen Schanker , Christine Harrison , Chris Mcclain , Braden Parker , Marrow Transplant Research , National Marrow Donor Program , European Commission , International Blood , Exchange Commission , European Union , San Raffaele Telethon Institute For Gene Therapy , European Medicines Agency , Business Development At Be , Corporate Affairs , Orchard Therapeutics , Senior Vice President , New Business Development , Marrow Transplant , Product Characteristics , San Raffaele Telethon Institute , Gene Therapy , Private Securities Litigation Reform Act , Late Infantile Variant ,